U.S., Jan. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07328633) titled 'Prehabilitation Plus ERAS in Gastric Cancer Surgery' on Sept. 19, 2025.
Brief Summary: This study aims to evaluate the impact of pre-habilitation combined with Enhanced Recovery After Surgery (ERAS) versus ERAS perioperative management alone on clinical outcomes in patients with gastric cancer undergoing neoadjuvant chemotherapy and laparoscopic (robotic) gastrectomy. The study is a single-center, randomized controlled trial involving patients aged 18-75 years. Participants will be randomly assigned to either a pre-habilitation program plus ERAS or ERAS alone. The primary outcome is the incidence of postoperative complications withi...